Request Processed
Your registration request has been processed. We will contact you soon.
Register
First name
Last name
Email
Company
Toggle navigation
Toggle navigation
Login
Register
About
Contact Us
1
2
3
4
5
…
Next ›
Last »
FDA “Mission Is Unchanged,” Acting Commissioner Brenner Assures Staff; “Radical” Changes Coming, But Agency Will “Eventually” Be In “A Much Stronger Place”
March 27, 2025
FDA Facing Deep Job Cuts To Non-Review Functions Under HHS Reorganization Plan; IT, HR, Procurement, Comms – And Policy – Will Be Centralized At Department Level
March 27, 2025
Prevision Policy Clips | FDA Faces 3,500 Job Cuts In HHS Reorganization Plan, But Reviewers/Inspectors Will Be Spared
March 27, 2025
Prevision Policy Clips | The Makary Era At FDA Begins: Senate Confirms Martin Makary As FDA Commissioner
March 26, 2025
Prevision Policy Clips | FDA Deputy Commissioner For Operations/COO Is DoD Veteran Barclay Butler
March 25, 2025
Prevision Policy Clips | White Oak U-Turn: Senate HELP General Counsel Barrett Tenbarge To Remain With Committee, No Longer Headed To FDA
March 24, 2025
A Glow Up For VAERS? Rebranding Vaccine Safety Systems With More Robust, Community-Level Data Could Address Vaccine Hesitancy, Gottlieb Says
March 21, 2025
Prevision Policy Clips | “Most Favored Nation” Drug Pricing Options Outlined By GOP Think Tank
March 21, 2025
Vaccine Uptake Depends On “Compelling Evidence,” Not “Mandates,” FDA’s Marks Says; Planning Ahead May Make It Easier To Measure Indirect Benefits To Encourage Adoption
March 20, 2025
Prevision Policy Clips | Oz Faces GOP Stumbling Block On Road To CMS: Missouri Republican Sen. Hawley
March 20, 2025
Prevision Policy Clips | FTC Down To Two Commissioners After Trump “Fires” Democratic Commissioners
March 19, 2025
Prevision Policy Clips | “Newly Proposed” Benefits Is Focus Of ICER/NICE/Canada Drug Agency Working Group
March 18, 2025
Office Of Therapeutic Products Attempting To Weather Staff Cuts: “We’re Going To Do Our Best,” CBER Director Marks Says
March 17, 2025
Prevision Policy Clips | Return-To-Office Day For FDA: Expect Disruptions
March 17, 2025
CMS Nominee Oz Delivers Wizardly Performance In Confirmation Hearing; Drug Pricing Is Not Major Focus, But Oz Pledges To Use Price Negotiation, Support Sickle Cell Demo
March 14, 2025
Prevision Policy Clips | Flu Strain Selections Announced By FDA After Internal Meeting
March 14, 2025
FDA Rare Disease “Case Studies” Illustrate Dose Optimization (Sanofi’s Xenpozyme) And Single Trial Efficacy Standard (Sentynyl’s Nulibry)
March 13, 2025
FDA Commissioner Nominee Makary Clears Committee After Chief Counsel Departs; CDC Nominee Weldon Withdrawn By White House
March 13, 2025
Prevision Policy Clips | FDA Reverses Course On Chief Counsel Ahead Of Makary Confirmation Vote: Hilary Perkins “Has Resigned
March 13, 2025
FDA Gene & Cell Therapy Office Leadership Ranks Are Thinning Fast: Office of Clinical Evaluation Director Fashoyin-Aje, Cell Therapy CMC Head Lombardi Are Latest Departures
March 12, 2025
Prevision Policy Clips | FDA Chief Counsel Will Be Hilary Perkins After HHS Reorganizes
March 12, 2025
Makary’s Team Takes Shape: FDA Deputy For Legislation Is Former Hill Staffer With User Fee/21CC Experience Graham; Chief Of Staff Is Traficant
March 11, 2025
Flat-Line Funding Is Best Case For FDA Heading Into Shutdown Uncertainty, Return-To-Office Deadlines; Pediatric PRV Still In Limbo
March 11, 2025
Prevision Policy Clips | FDA Medical Reviewers, Manufacturing Inspectors Not Eligible for HHS “Buyout”
March 11, 2025
Prevision Policy Clips | CMS Nominee Oz Set For Confirmation Hearing March 14
March 10, 2025
1
2
3
4
5
…
Next ›
Last »